NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:28
NeurAxis Enterprise Value : 68.14M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 68.14M |
| November 04, 2026 | 77.49M |
| November 03, 2026 | 74.00M |
| November 02, 2026 | 74.25M |
| October 30, 2026 | 80.86M |
| October 29, 2026 | 86.10M |
| October 28, 2026 | 86.34M |
| October 27, 2026 | 83.73M |
| October 26, 2026 | 82.35M |
| October 23, 2026 | 84.22M |
| October 22, 2026 | 86.72M |
| October 21, 2026 | 90.71M |
| October 20, 2026 | 89.46M |
| October 19, 2026 | 89.84M |
| October 16, 2026 | 87.97M |
| October 15, 2026 | 88.46M |
| October 14, 2026 | 73.38M |
| October 13, 2026 | 73.00M |
| October 12, 2026 | 75.75M |
| October 09, 2026 | 78.36M |
| October 08, 2026 | 76.37M |
| October 07, 2026 | 77.12M |
| October 06, 2026 | 76.49M |
| October 05, 2026 | 81.11M |
| October 02, 2026 | 80.61M |
| Date | Value |
|---|---|
| October 01, 2026 | 81.36M |
| September 30, 2026 | 83.85M |
| September 29, 2026 | 88.71M |
| September 28, 2026 | 84.22M |
| September 25, 2026 | 86.22M |
| September 24, 2026 | 88.59M |
| September 23, 2026 | 83.10M |
| September 22, 2026 | 83.10M |
| September 21, 2026 | 80.98M |
| September 18, 2026 | 86.84M |
| September 17, 2026 | 87.09M |
| September 16, 2026 | 78.49M |
| September 15, 2026 | 63.03M |
| September 14, 2026 | 63.65M |
| September 11, 2026 | 63.53M |
| September 10, 2026 | 62.90M |
| September 09, 2026 | 63.40M |
| September 08, 2026 | 65.65M |
| September 04, 2026 | 66.27M |
| September 03, 2026 | 67.64M |
| September 02, 2026 | 66.15M |
| September 01, 2026 | 64.40M |
| August 31, 2026 | 66.89M |
| August 28, 2026 | 66.77M |
| August 27, 2026 | 67.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 224.21B |
| AngioDynamics, Inc. | 477.80M |
| Alphatec Holdings, Inc. | 1.734B |
| AtriCure, Inc. | 3.030B |
| Baxter International, Inc. | 19.28B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.086M |
| Revenue (Quarterly) | 1.929M |
| Total Expenses (Quarterly) | 4.014M |
| EPS Diluted (Quarterly) | -0.1879 |
| Gross Profit Margin (Quarterly) | 85.87% |
| Profit Margin (Quarterly) | -108.1% |
| Earnings Yield | -12.56% |
| Normalized Earnings Yield | -12.52 |